February 3, 2021 DUBLIN and LONDON, Feb. 3, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies have entered into a definitive agreement for Jazz to acquire GW for $220.00 per American Depositary Share (ADS), in the form of $200.00 in cash and $20.00 in Jazz ordinary shares, for a total consideration of $7.2 billion, or $6.7 billion net of GW cash. The…
Read more
Aurora Cannabis announced it has entered into a strategic agreement with MedReleaf Australia. The companies have signed a five-year supply agreement, which provides for MedReleaf to act as the exclusive supplier in Australia of Aurora’s MedReleaf, CanniMed and Aurora brands. Products covered by the agreement will be EUGMP certified and include dried flower, oils, and…
Read more
The Valens Company closed its previously announced bought deal public offering of units of the Company for total gross proceeds of $39.7mm. The Company sold 19.4mm Units at a price of $2.05/unit, including 2.3mm units sold pursuant to the exercise of the underwriters’ over-allotment option. The Company plans to use $32.0mm of the net proceeds…
Read more
TGOD unveiled plans to transition its medical business to a wholesale model, in line with other pharmaceutical products’ distribution models, working with national partner Medical Cannabis by Shoppers to unlock growth potential. Patient-centered approach eliminates the need to register with multiple licensed producers to access a broad portfolio of medical cannabis products. The transition helps…
Read more